The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, M. R.
Right arrow Articles by Hansen, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, M. R.
Right arrow Articles by Hansen, T. H.
The Journal of Immunology, 2001, 166: 6686-6692.
Copyright © 2001 by The American Association of Immunologists

Association of ERp57 with Mouse MHC Class I Molecules Is Tapasin Dependent and Mimics That of Calreticulin and not Calnexin1

Michael R. Harris*, Lonnie Lybarger{dagger}, Yik Y. L. Yu{dagger}, Nancy B. Myers{dagger} and Ted H. Hansen2,{dagger}

* Department of Newborn Medicine, Children’s Hospital, St. Louis, MO 63110; and {dagger} Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Before peptide binding in the endoplasmic reticulum, the class I heavy (H) chain-{beta}2-microglobulin complexes are detected in association with TAP and two chaperones, TPN and CRT. Recent studies have shown that the thiol-dependent reductase, ERp57, is also present in this peptide-loading complex. However, it remains controversial whether the association of ERp57 with MHC class I molecules precedes their combined association with the peptide-loading complex or whether ERp57 only associates with class I molecules in the presence of TPN. Resolution of this controversy could help determine the role of ERp57 in class I folding and/or assembly. To define the mouse class I H chain structures involved in interaction with ERp57, we tested chaperone association of Ld mutations at residues 134 and 227/229 (previously implicated in TAP association), residues 86/88 (which ablate an N-linked glycan), and residue 101 (which disrupts a disulfide bond). The association of ERp57 with each of these mutant H chains showed a complete concordance with CRT, TAP, and TPN but not with calnexin. Furthermore, ERp57 failed to associate with H chain in TPN-deficient .220 cells. These combined data demonstrate that, during the assembly of the peptide-loading complex, the association of ERp57 with mouse class I is TPN dependent and parallels that of CRT and not calnexin.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
The biosynthesis of oligomeric proteins entering the secretory pathway is facilitated by chaperone proteins in the endoplasmic reticulum (ER)3 that are thought to provide quality control to insure correct folding. For example, MHC class I molecules require assembly in the ER of three subunits, a heavy (H) chain, {beta}2-microglobulin ({beta}2m), and peptide ligand (1). Recent studies demonstrate that assembly intermediates of class I are associated with several ER proteins including calnexin (CXN), calreticulin (CRT), TAP, tapasin (TPN), and ERp57 (2). The dynamics of ER chaperone interactions with class I assembly intermediates and the selective roles of each ER chaperone in class I biogenesis remain topics of considerable interest and controversy.

Although several details remain unclear or controversial, the temporal order of events involved in class I assembly is starting to emerge. As the MHC class I H chain is translocated into the ER, intrachain disulfide bonds are formed within the {alpha}2 and {alpha}3 domains (3). Interestingly, the formation of these two H chain disulfide bonds may be temporally distinct (4, 5). This observation raises the possibility that the {alpha}3 and {alpha}2 disulfide bond formation may correspond with H chain interaction with {beta}2m and peptide, respectively, according to a kinetic model (6, 7). Both non- and disulfide-bonded H chains can be detected in association with CXN, an ER chaperone implicated in either stabilizing free H chains and/or promoting H chain assembly with {beta}2m (3, 8, 9). After {beta}2m assembly, class I-{beta}2m heterodimers are detected in association with CRT-TAP-TPN, a complex referred to here as the peptide-loading complex (2, 10, 11, 12, 13, 14, 15, 16). The order of assembly of this peptide-loading complex is unclear (2). However, once a peptide binds to form the fully assembled class I molecule, it is no longer associated with the peptide-loading complex, thus releasing class I molecules from the ER for transit to the cell surface (10, 11, 12).

Several H chain mutations have been described that disrupt its interaction with members of the peptide-loading complex. For example, {alpha}1 residue N86 (17), {alpha}2 residues 116 (18) and 128–136 (19, 20, 21), and {alpha}3 residues 223–229 (12, 22, 23) have all been implicated in H chain interaction with the peptide-loading complex. However, it remains unclear which, if any, of these are direct sites of interaction with TAP, TPN, or CRT. Part of the problem in defining direct interaction sites is the fact that cooperative binding among members of the peptide-loading complex may be required for their stable association with class I (21, 24). Furthermore, these mutagenesis approaches have been technically limited because of the lack of reagents capable of precipitating ER proteins while associated with class I molecules and the lack of reagents capable of identifying specific class I alleles while associated with ER molecules. Despite these limitations, a model has been proposed whereby CRT specifically interacts with the N-linked glycan at H chain residue 86, whereas TPN interacts with residue 128–136 and 223–229 in the {alpha}2 and {alpha}3 domains, respectively (25). However, this model must be considered speculative because of the aforementioned cooperative binding issue as well as the fact that the model does not consider the contribution of the most recently identified participant in class I assembly, ERp57 (26, 27, 28).

ERp57 has thiol-dependent reductase activity (29), cysteine-dependent protease activity (30, 31), and is known to interact with glycoproteins in a manner that can involve forming complexes with either CXN and CRT (32, 33, 34). Three recent reports demonstrated that ERp57 is detected in association with class I molecules before peptide binding (26, 27, 28). However, important details regarding this association remain controversial, such as whether ERp57 association with class I is dependent upon TPN or whether ERp57 can associate with class I before its association with other members of the peptide-loading complex. Resolution of this controversy could help define the primary function of ERp57, which, reportedly, may include H chain disulfide bond formation, peptide trimming, or ER degradation of misfolded class I proteins (26).

In this report, we study the association of a series of H chain mutations with ERp57, TPN, and other ER molecules associated with class I during its assembly. This analysis includes mutations in all three extracellular domains that have been reported to disrupt H chain association with CRT-TPN-TAP and have not been previously tested for association with ERp57. The advantage of a mutagenesis approach is that a particular mutant may reduce or disrupt class I interaction with a particular ER protein and may thus prolong associations with other ER proteins that may otherwise be difficult to detect. In this regard, perhaps the most interesting mutation tested is C101S, because it prevents the disulfide bridge in the {alpha}2 domain that is a critical for the formation of the peptide binding groove. The simplest model consistent with these findings suggests that, during the assembly of the peptide-loading complex, ERp57 associates with CRT, and ERp57-CRT complexes only bind class I-{beta}2m in the presence of TPN.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Cell lines

All the cell lines used in this report have been previously described. Mutant forms of Ld expressed in various cell lines are referred to by a single letter designation of native amino acid followed by the position number, which is then followed by a single letter designation of the newly introduced amino acid. The mouse L cell transfectants used in this study were: L-Ld (34), L-Ld D227K and L-Ld D227K/E229K (12), L-Ld K131D and L-Ld T134K (21), L-Ld N86Q, L-Ld N176Q, L-Ld N86K, and L-Ld S88W (17), and L-Ld C101S (16). Two human lymphoblastoid cell lines transfected with the Ld cDNA were also used, LCL721.220-Ld and LCL721.221-Ld (13, 35, 36).

Antibodies

The Abs used in this study are listed in Table IGo. Briefly, mAb 30-5-7 (37) was used to precipitate fully assembled forms of Ld, and mAb 64-3-7 (38) was used to precipitate open forms of Ld indiscriminate of their {beta}2m association (39, 40, 41). The mAb 64-3-7 was also used in Western blot analyses, in which it detects total Ld independent of conformation (12). The mAb 148.3 (42) to human TAP was a kind gift of Dr. R. Tampe, and mAb BBM1 (43) to human {beta}2m was obtained from American Type Culture Collection (Manassas, VA). Rabbit Abs to CXN were purchased from StressGen Biotechnologies (Victoria, Canada), and chicken Ab to CRT (PA1-903) was purchased from Affinity BioReagents (Golden, CO). The rabbit Ab to mouse TAP and human TAP were both made to peptide sequences derived from the C-termini and have been previously described (17). Three new reagents are reported here. A rabbit Ab to mouse ERp57 (number 2890) was produced to a peptide REATNPPIIQEEKPKKKKKAQEDL representing the C-terminal amino acids of mouse ERp57 (28). The specificity of this reagent was determined based on the appropriate m.w. of the precipitin band and the fact that it was detected in association with incompletely and not fully assembled class I molecules. This anti-mouse ERp57 (number 2890) was used for precipitation or Western blotting. A rabbit polyclonal Ab (number 2668) and an Armenian hamster mAb (5D3) were produced to peptide EDAGGGGLSKKPATLLLRHGPRGP, representing residues 11–34 on mouse TPN (44). As shown in Fig. 1Go, both the anti-TPN polyclonal and mAbs were found to be specific for mouse TPN, as determined in a Western blot analysis of cell lysates of .221 (human TPN-positive) cells, .220 (human TPN-negative) cells, and .220 cells transfected with mouse TPN. The rabbit anti-mouse TPN (number 2668) was used in precipitation and Western blot assays, whereas the mAb 5D3 to mouse TPN was used for Western blotting.


View this table:
[in this window]
[in a new window]
 
Table I. Abs used in this study1

 


View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 1. Specificity of the rabbit polyclonal Ab (number 2668) and hamster mAb 5D3 for mouse TPN. Cell lysates from .221, .220, and .220 transfected with mouse TPN were tested by Western blotting with the indicated Ab. These Abs were raised against a region of mouse TPN that shows a divergence from human TPN. Furthermore, this region is absent in the truncated human TPN produced by .220 cells (51 ). Thus, the finding that no unique bands are present in .221 cells (human TPN-positive) relative to .220 cells demonstrates that these Abs are mouse TPN specific and that the common bands seen with rabbit antiserum are nonspecific.

 
Immunoprecipitation

Cells were washed three times in cold PBS and were lysed in Tris-buffered saline that contained 1% digitonin (Wako, Richmond, VA) with 20 mM iodoacetamide (Sigma, St. Louis, MO) and 0.5 mM freshly added PMSF. The lysis buffer was supplemented with a saturating amount of mAb or rabbit Ab before addition to pelleted cells. After incubation for 45 min on ice, nuclei were removed by centrifugation, and lysates were incubated with protein A-Sepharose beads (Pharmacia, Piscataway, NJ). The beads were washed four times with 0.1% digitonin in 10 mM Tris-buffered saline (pH 7.4) with 20 mM iodoacetamide, and the samples were eluted by boiling in 0.125 M Tris (pH 6.8)-2% SDS-12% glycerol-2% bromophenol blue. For Western blots, SDS-PAGE gels were transferred to Immobilon P membranes (Millipore, Bedford, MA). After overnight blocking in 10% milk-0.05% Tween 20, membranes were incubated in a dilution of Ab for 2 h, washed three times with PBS-0.05% Tween 20, and incubated for 1 h with biotin-conjugated goat anti-mouse or anti-rabbit IgG (Caltag Laboratories, San Francisco, CA), goat anti-Armenian hamster IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) or rabbit anti-chicken/turkey IgG (Zymed, San Francisco, CA). Following three washes with PBS-0.05% Tween 20, membranes were incubated for 1 h with streptavidin-conjugated HRP (Zymed), washed three times with PBS-0.3% Tween 20, and incubated with ECL chemiluminescent reagents (Amersham Pharmacia Biotech, Piscataway, NJ).


    Results and Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Using Ld to study class I interactions with ER proteins is advantageous because mAb 64-3-7 can be used to specifically detect this class I allele while associated with CXN, CRT, TAP, TPN, and/or ERp57 (12, 21). In other words, the detection of Ld by mAb 64-3-7 is not sterically blocked when Ld binds any of these ER proteins, either directly or in complexes. Thus, several Ld mutants were constructed to probe how class I assembly intermediates interact with ER proteins during class I biogenesis. To further strengthen the mutagenesis approach reported here, new reagents were developed including a rabbit serum to mouse ERp57 and mouse TPN that can precipitate these ER proteins while associated with class I (Table IGo). Furthermore, a new hamster mAb that specifically detects mouse TPN by Western blotting was developed (Fig. 1Go). With these combined reagents, the association of mutant H chains with salient ER proteins could be rigorously tested.

Mutations in H chain residues 227 and 229 disrupt association with ERp57, TPN, CRT, but not CXN

Several studies have now demonstrated, using mouse Ld (12), Db (22), or Dd (23) molecules, that mutations in the {alpha}3 domain can disrupt association with TPN-TAP. To determine whether {alpha}3 mutation also affects ERp57 association, lysates of cells expressing Ld H chains with a single mutation at residue D227K or a double mutation at residues D227K and E229K were tested. Results obtained by precipitating Ld, Ld D227K, or Ld D227K/E229K and then blotting with anti-CXN, -CRT, -ERp57, -TAP, -TPN, or -Ld H chain are shown in Fig. 2Go. As shown, comparable amounts of Ld, Ld D227K, and Ld D227K/E229K H chains were detected in all three lysates, and all three of these H chains displayed strong association with CXN. By contrast with these findings, the {alpha}3 mutant H chains displayed weaker (Ld D227K) or no (Ld D227K/E229K) association with ERp57 (Fig. 2Go) or with CRT, TAP, or TPN, as also previously reported (12, 21). To extend these findings, precipitations were also performed using anti-ERp57 or anti-TPN followed by blotting for Ld H chain association. In data not shown, significantly less {alpha}3 mutant Ld H chain was detected in association with either TPN or ERp57 compared with wild-type Ld H chains. It is noteworthy that, in all of our comparisons, the double mutation was considerably more efficacious at ablating associations with ER proteins relative to the single mutation. This finding is consistent with an earlier report by Kulig et al. (22). In any case, ERp57 association with these {alpha}3 mutants clearly parallels that of TAP-TPN-CRT. Furthermore, based on studies of {alpha}3 mutations of Dd that were associated with CRT and not TPN-TAP, it was predicted that the {alpha}3 domain may be a site on the class I H chain that directly interacts with TPN. In such a model, it is assumed that only TPN, and not TAP, directly contacts class I (14).



View larger version (42K):
[in this window]
[in a new window]
 
FIGURE 2. Mutation at residues in the {alpha}3 domain disrupt association with ERp57, CRT, TAP and, TPN but not with CXN. Lysates of L-Ld, L-Ld D227K, and L-Ld D227K/E229K cells were precipitated with mAb 64-3-7 to specifically detect open forms of Ld. Aliquots representing cell equivalents of each of these precipitates were then blotted with the Ab listed along the left side. Specific blotting reagents used for this experiment were anti-CXN (SPA-860), anti-CRT (PA1-903), anti-ERp57 (2890), anti-TAP (502), anti-TPN (mAb 5D3), and anti-Ld (64-3-7).

 
Mutation in the {alpha}2 loop residue 134 of the H chain ablates ERp57 association

Residue 134 was originally shown to affect class I association with the peptide-loading complex in studies of HLA-A2.T134K (19, 20). More recent studies in our laboratory have defined the extent of the region surrounding residue 134 involved in TAP-TPN-CRT association by mutagenesis of Ld (21). In this previous report, amino acid substitutions of Ld residues 128–136 significantly reduced association with TAP-TPN-CRT with the exception of Ld K131D. Interestingly, the K131D mutation appeared as a hypermorph in terms of loading complex association, because it had enhanced association with TAP-TPN in comparison with wild-type Ld (21). Furthermore, of the mutations that reduced association, T134K was among the most efficacious. To determine whether the K131D and T134K mutations affected ERp57 association, lysates of L cells expressing wild-type Ld, Ld K131D, or Ld T134K were precipitated with mAb 64-3-7 and blotted with anti-CXN, anti-CRT, anti-ERp57, anti-TAP, and anti-TPN. As shown in Fig. 3GoA, Ld and Ld K131D molecules were found to be associated with all ER proteins tested. By contrast, Ld T134K showed no detectable association with ERp57, TAP, TPN, and CRT. Importantly, each of these cell lines synthesized readily detectable Ld H chains and displayed high levels of CXN association (Fig. 2GoA). However, the level of Ld H chains expressed by each of these cell lines was clearly disparate, potentially influencing the detection of associated ER proteins. Thus, this experiment was repeated using samples in which the Ld H chains were normalized based on expression differences determined by densitometry (see Fig. 3GoB legend for details). Normalizing for Ld H chain expression resulted in similar qualitative differences in ER protein associations as obtained using cell equivalents (compare Fig. 3Go, A and B). Furthermore, normalizing for Ld H chain provided clear evidence that Ld K131D had increased association with CRT-ERp57-TAP-TPN, whereas Ld T134K lacked association with these same ER proteins (Fig. 3GoB). Interestingly, CXN associated comparably with Ld, Ld K131D, or Ld T134K. Thus, ERp57 association with the K131D and T134K mutants correlates precisely with that of the peptide-loading complex (TAP-TPN-CRT) and not CXN. Based on studies of HLA-B27 mutants (M. R. Harris, L. Lybarger, N. B. Myers, C. Hilbert, J. Solheim, T. H. Hansen, and Y. Y. L. Yu, manuscript in preparation), it was predicted that residues around 134 of the H chain may directly interact with TPN.



View larger version (42K):
[in this window]
[in a new window]
 
FIGURE 3. Mutation in the {alpha}2 domain at residue 134 disrupts H chain association with ERp57 as well as TAP, CRT, and TPN. A, Aliquots of lysates representing cell equivalents of L-Ld, L-Ld K131D, and L-Ld T134K were precipitated with 64-3-7 and blotted with the various Abs to ER proteins (specific Abs listed in Fig. 1Go legend). B, Same as A except the quantity of sample loaded was normalized according to the relative amount of Ld H chain that was determined by densitometry. Relative levels of Ld H chain were determined to be 8:1:1 for L-Ld, L-Ld K131D, and L-Ld T134K, respectively.

 
The N-linked glycan at residue 86 is specifically required for H chain association with ERp57 and CRT but not CXN

We previously showed that association of Ld with the complex of TAP-TPN-CRT requires the N-linked oligosaccharide at residue 86 (17). This conclusion was based on mutagenesis studies of Ld, a class I molecule with three N-linked glycans, one in each of the three external domains. In this previous study, Ld mutation at N86 was reported to ablate association with TPN-TAP-CRT. To determine whether ERp57 association with Ld shows this same glycan dependency, two mutations that ablate the N86-linked glycan were tested, N86K and S88W. Thus, lysates of cells expressing wild-type Ld or Ld N86K and Ld S88W mutant molecules were precipitated with mAb 64-3-7 to detect Ld H chains and were blotted to detect associated proteins (Fig. 4GoA, cell equivalents, and Fig. 4GoB, normalized Ld H chains). In a reciprocal experiment, lysates of cells expressing wild-type Ld or Ld N86K and Ld S88W mutant molecules were precipitated with Ab to the various ER proteins and blotted with mAb 64-3-7 to detect associated Ld H chains (Fig. 4GoC). Using each of these approaches, neither the Ld N86K or Ld S88W mutants were found to be associated with ERp57, CRT, TPN, or TAP. It should also be noted that both mutants were associated with CXN. Thus, these combined studies clearly show that ERp57, like other members of the loading complex, is dependent upon the N86 glycan for association with the class I H chain.



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 4. The N-linked glycan at residue 86 is required for H chain association with ERp57, CRT, TPN, and TAP but not with CXN. A, Aliquots of lysates representing cell equivalents of L-Ld, L-Ld N86K, and L-Ld S88W were precipitated with mAb 64-3-7, and then each precipitate was blotted with the Ab listed along the left (see Fig. 1Go legend for specific Ab used for blotting). B, Same as A except quantity of sample loaded was normalized according to the relative amount of Ld H chain that was determined by densitometry to be 16:2:1 for L-Ld, L-Ld N86K, and L-Ld S88W, respectively. C, Normalizing for the amount of Ld H chains, aliquots of lysates of L-Ld, L-Ld N86K, and L-Ld S88W were precipitated with anti-TAP (502), anti-TPN (2668), anti-ERp57 (2890), or anti-open Ld (64-3-7). Each precipitate was then blotted with mAb 64-3-7.

 
Based on the lectin activity of CRT (33), it was proposed that N86 is specifically required for CRT to interact with the class I H chain (17). Given the validity of this conclusion, the findings in Fig. 3Go indicated that TPN-TAP and ERp57 are dependent upon CRT to form stable, steady-state associations with Ld. Interestingly, CXN binds H chains lacking the N86 glycan (Fig. 3GoA and Ref. 17). However, CXN association with Ld is clearly increased by N-linked glycosylation (M. R. Harris and T. H. Hansen, unpublished observation) as predicted from studies using glucosidase inhibitor castonospermine in studies of other class I molecules (45, 46). The advantage of the mutagenesis approach taken here is that Ld has three N-linked glycans, allowing us to clearly demonstrate that the N86 glycan is uniquely required for H chain association with CRT and the loading complex. By contrast, preventing complete glycosylation can result in aggregation and nonspecific association of aglycosylated proteins with CXN (47). The fact the CRT requires the glycan in the {alpha}1 domain of the H chain may be influenced by the fact that CRT is a soluble protein, whereas CXN is membrane anchored. Furthermore, the location of the H chain {alpha}1 domain glycan positions CRT near the site of peptide loading, possibly rendering CRT better able to interact with other members of the peptide-loading complex.

Mutation at cysteine residue 101 of the H chain disrupts association ERp57

All MHC class I molecules have two disulfide bonds, one between residues C101 and C164 in the {alpha}2 domain and the other in the {alpha}3 domain between C203 and C259. Because ERp57 has thiol-dependent reductase activity and has been implicated in the peptide-loading complex, it is attractive to speculate that ERp57 may facilitate disulfide bond formation in the {alpha}2 domain. If this were the case, then the C101S mutant might be expected to display high levels of ERp57 association. To test this hypothesis, lysates of L-Ld C101S cells and control L-Ld cells were precipitated with mAb 64-3-7 and then blotted with Abs to various ER proteins. As shown in Fig. 5GoA, Ld C101S was found to be highly associated with CXN. By contrast, ERp57, CRT, TPN, and TAP displayed substantially reduced association with Ld C101S relative to wild-type Ld. Furthermore, when these respective lysates were precipitated with anti-TAP, anti-TPN, or anti-ERp57 (Fig. 5GoB), only wild-type Ld, and not Ld C101S, molecules were detected by blotting for Ld H chains. Thus, C101S mutation of Ld severely reduces its ability to associate with ERp57 as well as TAP, TPN, and CRT but not CXN. It should be noted that failure of Ld C101S to associate with TAP-TPN-CRT proteins confirms an earlier report (16) and is consistent with studies that used DTT to identify H chain disulfide bond intermediates (5, 48, 49). These combined studies indicate that the {alpha}2 disulfide bond, like the {alpha}3 disulfide bond, likely formed before steady-state association of H chain with TAP-TPN-CRT. The original observation reported here is that formation of the H chain {alpha}2 disulfide bond is also required for ERp57 to display steady-state association. The fact that the C101S mutation does not increase H chain association with ERp57 raises questions regarding the role of ERp57 in formation of the disulfide bond in the {alpha}2 domain of the class I H chain.



View larger version (33K):
[in this window]
[in a new window]
 
FIGURE 5. Mutation C101S disrupts H chain association with ERp57, CRT, TPN, and TAP but not with CXN. A, Samples representing cell equivalents of lysates from L-Ld C101S and L-Ld were precipitated with mAb 64-3-7, and aliquots of each of these precipitates were blotted with the reagent listed along the left (specific identity of reagents used listed in legend of Fig. 1Go). B, Aliquots of lysates of L-Ld C101S and L-Ld were immunprecipitated with anti-ERp57 (2890), anti-TAP (502), anti-TPN (2668), or anti-Ld (mAb 64-3-7). All precipitates were then blotted with mAb 64-3-7.

 
ERp57 association with Ld is not detected in human TPN-deficient .220 cells

There are conflicting reports in the literature as to whether human class I H chains are detected in association with ERp57 in TPN-deficient .220 cells. Furthermore, to the best of our knowledge, there are no reports of the TPN dependency of ERp57 association with mouse class I. To address this question, ERp57-Ld association was compared in TPN-deficient .220-Ld and TPN-positive .221-Ld cells. From lysates of each of these cell lines, Ld molecules were precipitated with either mAb 30-5-7, which detects fully assembled Ld-{beta}2m-peptide heterotrimers, or mAb 64-3-7, which detects open forms of Ld H chains in a {beta}2m-independent manner. In this experiment, .220-Ld and .221-Ld lysates were also precipitated by a mAb to human TAP (148.3) and a mAb to human {beta}2m (BBM1). As indicated in Fig. 6Go, each of these precipitates was blotted with anti-human TAP or anti-human ERp57. The experiment shown in Fig. 6Go makes several important points. As previously noted, only 64-3-7-positive forms of Ld are detected in association with TAP (12), and this association is only seen in .221-Ld cells and not .220-Ld cells (36). Interestingly, ERp57-Ld association showed the identical result. Thus, Ld association with ERp57, like TAP, is TPN dependent. Furthermore, {beta}2m association with ERp57 was only observed in .221-Ld, suggesting that Ld-{beta}2m heterodimers require TPN to maintain stable association with ERp57. Furthermore these data show that ERp57 only interacts with Ld-{beta}2m heterodimers and not free H chains.



View larger version (45K):
[in this window]
[in a new window]
 
FIGURE 6. Ld is only detectable in association with ERp57 in the presence of functional TPN. Aliquots of lysates of .220-Ld and .221-Ld were precipitated with 30-5-7 (assembled Ld), 64-3-7 (open Ld), 148.3 (anti-human TAP), or BBM1 (anti-human {beta}2m). Each of these precipitates was then blotted with anti-human TAP (148.3) or anti-ERp57 (2890).

 
In summary, multiple lines of evidence are presented showing that ERp57 association with mouse Ld correlates precisely with TAP-TPN-CRT and not CXN. This finding clearly validates the conclusion that ERp57 is a bona fide member of the peptide-loading complex (26, 27, 28) and, furthermore, suggests a model consistent with the data reported here as well as most of the published literature (2). In this model, ERp57-H chain-{beta}2m complexes are only associated with CRT and not CXN. Given our findings as well as certain other published reports using .220 cells (26), we propose that ERp57-CRT complexes are TPN dependent in their association with class I-{beta}2m complexes. This latter dependency is consistent with published findings that CRT is also TPN dependent in its association with class I (14, 16). Although ERp57 could bind directly to TPN and not CRT, we consider this unlikely. ERp57 is known to interact in combination with CRT or CXN with several different proteins besides class I (32, 33, 34), whereas TPN is thought to be a class I-specific chaperone (2). Thus, the simplest model consistent with these conclusions is that, during the assembly of the peptide-loading complex, ERp57 binds CRT, and ERp57-CRT only binds to class I-{beta}2m in the presence of TPN.

Interestingly, a recent report by Diedrich et al. (50) used human cells to define an ER complex of ERp57-CXN-TAP-TPN. These authors proposed that, coincident with class I binding, this intermediate complex replaces CXN with CRT to form the peptide-loading complex. However, regardless of the fate of this intermediate, the study by Diedrich et al. (50) is in complete agreement with our report concerning two underlying conclusions: first, that the steady-state association of ERp57 with class I is dependent upon TPN and, second, that when class I is bound, the loading complex includes steady-state levels of CRT and not CXN. This concordance between these two studies indicates that the rules governing the association of ERp57 with the peptide-loading complex are similar for mice and humans. It should be noted that ERp57 can clearly also be detected in association with CXN (32, 33, 34, 50), but ERp57 is only detected in association with CRT when class I is also bound.

The fact that we did not detect ERp57 associated with class I assembly intermediates that were not also associated with CRT-TPN-TAP is in apparent conflict with two recent reports (28, 49). In one of these reports, a synchronized cell translation system was used to demonstrate that ERp57 might interact with class I before folding, disulfide bond formation, and subsequent association with TAP and other members of the loading complex (49). Using our approach, we cannot rule out the existence of ERp57-H-chain-{beta}2m complexes lacking TPN. However, such complexes would have to exist transiently and, thus, lack steady-state detection in our assays. In another report, ERp57 association with class I was reported to be TPN- and {beta}2m-independent (28). These findings are in conflict with our data and other reports. For example, we report here that five different H chain mutations that disrupt association with TPN-TAP also disrupt ERp57 association with class I. Furthermore, both in our studies with Ld (Fig. 5Go) and a report by Hughes and Cresswell (26) about HLA-B8, ERp57 association was detected in TPN-positive .221 cells and not TPN-deficient .220 cells. There are also several reports confirming the importance of {beta}2m assembly for H chain association with CRT and TPN-TAP (10, 11, 12, 16). Thus, we favor the model that stable association of ERp57 with class I is TPN dependent and correlates precisely with CRT association. This timing of ERp57 association with class I, as well as the failure to detect steady-state association of ERp57 with the C101S H chain mutant, suggests that ERp57 may have class I-related functions other than disulfide bond formation. For example, coincident association with class I of ERp57 and TPN-TAP may reflect an important role of Erp57 in final peptide trimming or turnover or class I molecules with aberrant peptide loading.


    Acknowledgments
 
We are grateful to E. M. Wormstall for help with production of the rabbit antisera, Dr. K. Sheehan for help in producing the hamster mAb, and S. Harris for expert computer graphics.


    Footnotes
 
1 This study was supported by National Institutes of Health Grants AI19876 and AI42792 (to T.H.H.), AI07163 (to L.L. and Y.Y.L.Y.), and AI01498 (to M.R.H.). Back

2 Address correspondence and reprint requests to Dr. Ted H. Hansen, Department of Genetics, Box 8232, Washington University School of Medicine, St. Louis, MO 63110. E-mail address: hansen{at}genetics.wustl.edu Back

3 Abbreviations used in this paper: ER, endoplasmic reticulum; {beta}2m, {beta}2-microglobulin; CXN, calnexin; CRT, calreticulin; TPN, tapasin. Back

Received for publication November 30, 2000. Accepted for publication March 22, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Townsend, A., C. Ohlen, J. Bastin, H.-G. Lunggren, L. Foster, K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced with viral peptides. Nature 340:443.[Medline]
  2. Pamer, E., P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.[Medline]
  3. Tector, M., R. D. Salter. 1995. Calnexin influences folding of human class I histocompatibility proteins but not their assembly with {beta}2-microglobulin. J. Biol. Chem. 270:19638.[Abstract/Free Full Text]
  4. Ribaudo, R. K., D. H. Margulies. 1992. Independent and synergitic effects of disulfide bond formation, {beta}2-microglobulin, and peptides on class I MHC folding and assembly in an in vitro translation system. J. Immunol. 149:2935.[Abstract]
  5. Wang, H., G. G. Capps, B. E. Robinson, M. C. Zuniga. 1994. Ab Initio association with {beta}2-microglobulin during biosynthesis of the H-2Ld class I major histocompatibility complex heavy chain promotes proper disulfide bond formation and stable peptide binding. J. Biol. Chem. 269:22276.[Abstract/Free Full Text]
  6. Elliott, T., V. Cerundolo, J. Elvin, A. Townsend. 1991. Peptide-induced conformational change of the class I heavy chain. Nature 35:402.
  7. Elliott, T.. 1991. How do peptides associate with MHC class I molecules?. Immunol. Today 12:386.[Medline]
  8. Degan, E., D. B. Williams. 1991. Participation of novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules. J. Cell Biol. 112:1099.[Abstract/Free Full Text]
  9. Nossner, E., P. Parham. 1995. Species-specific differences in chaperone interaction of human and mouse MHC class I molecules. J. Exp. Med. 181:327.[Abstract/Free Full Text]
  10. Ortmann, B., M. Androlewicz, P. Cresswell. 1994. MHC class I/{beta}2-microglobulin complexes associate with the TAP transporter before peptide binding. Nature 368:864.[Medline]
  11. Suh, W-K., M. F. Cohen-Doyle, K. Fruh, K. Wang, P. A. Peterson, D. B. Williams. 1994. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322.[Abstract/Free Full Text]
  12. Carreno, B. M., J. C. Solheim, M. Harris, I. Stroynowski, J. M. Connolly, T. H. Hansen. 1995. TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. J. Immunol. 155:4726.[Abstract]
  13. III Grandea, A. G., M. J. Androlewicz, R. S. Athwal, D. E. Geraghty, T. Spies. 1995. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270:105.[Abstract/Free Full Text]
  14. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103.[Medline]
  15. Van Leeuwen, J. E. M., K. P. Kearse. 1996. Deglucosylation of N-linked glycans is an important step in the dissociation of calreticulin-class I-TAP complexes. Proc. Natl. Acad. Sci. USA 93:13997.[Abstract/Free Full Text]
  16. Solheim, J. C., M. R. Harris, C. S. Kindle, T. H. Hansen. 1997. Prominence of {beta}2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol. 158:2236.[Abstract]
  17. Harris, M. R., Y. Y. L. Yu, C. S. Kindle, T. H. Hansen, J. C. Solheim. 1998. Calreticulin and calnexin interact with different protein and glycan determinants during the assembly of MHC class I. J. Immunol. 160:5404.[Abstract/Free Full Text]
  18. Neisis, A., R. Wubbolts, X. Zang, C. Melief, J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196.[Abstract]
  19. Peace-Brewer, A. L., L. G. Tussey, M. Matsui, G. Li, D. G. Quinn, J. A. Frelinger. 1996. A point mutation in HLA-A*0102 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4:505.[Medline]
  20. Lewis, J. W., A. Neisig, J. Neefjes, T. Elliott. 1996. Point mutations in the {alpha}2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr. Biol. 6:873.[Medline]
  21. Yu, Y. L. Y., H. R. Turnquist, N. B. Myers, G. K. Balendiran, T. H. Hansen, J. C. Solheim. 1999. An extensive region of an MHC class I {alpha}2 domain loop influences interaction with the assembly complex. J. Immunol. 163:4427.[Abstract/Free Full Text]
  22. Kulig, K., D. Nandi, I. Bacik, J. J. Monaco, S. Vukmanovic. 1998. Physical and functional association of the major histocompatibility complex class I heavy chain {alpha}3 domain with the transporter associated with antigen processing. J. Exp. Med. 187:865.[Abstract/Free Full Text]
  23. Suh, W-K., M. A. Derby, M. F. Cohen-Doyle, G. J. Schoenhals, K. Früh, J. A. Berzofsky, D.B. Williams. 1999. Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain {alpha}3 domain. J. Immunol. 162:1530.[Abstract/Free Full Text]
  24. Bangia, N., P. J. Lehner, E. A. Hughes, M. Surman, P. Cresswell. 1999. The N-terminal region of tapasin is required to stabilize the MHC class I loading complex. Eur. J. Immunol. 29:1858.[Medline]
  25. Hansen, T., G. Balendiran, J. Solheim, D. Ostrov, S. Nathenson. 2000. Structural features of MHC class I molecules that might facilitate alternative pathways of presentation. Immunol. Today 21:83.[Medline]
  26. Hughes, E. A., P. Cresswell. 1998. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr. Biol. 8:709.[Medline]
  27. Morrice, N. A., S. J. Powis. 1998. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr. Biol. 8:713.[Medline]
  28. Lindquist, J. A., O. N. Jensen, M. Mann, G. J. Hammerling. 1998. ER-60, a chaperone with thiol reductase activity involved in MHC class I assembly. EMBO J. 17:2186.[Medline]
  29. Srivastava, S. P., N-Q Chen, Y-X Liu, J. L. Holtzman. 1993. Purification and characterization of a new isozyme of thiol:protein-disulfide oxidoreductase from rat hepatic microsomes: relationship of this isozyme to cytosolic phosphatidylinositol-specific phospholipase C form 1A. J. Biol. Chem. 266:20337.[Abstract/Free Full Text]
  30. Urade, R., M. Nasu, T. Moriyama, K. Wade, and M. Kito. 1992. Protein degradation by the phosphoinositide-specific phospholipase C-{alpha} family from rat liver endoplasmic reticulum. J. Biol. Chem.
  31. Otsu, M., R. Urade, M. Kito, F. Omura, M. Kituchi. 1995. A possible role of ER-60 protease in the degradation of misfolded proteins. J. Biol. Chem. 270:14958.[Abstract/Free Full Text]
  32. Elliott, J. G., J. D. Oliver, S. High. 1997. The thiol-dependent reductase ERp57 interacts specifically with N-glycosylated integral membrane proteins. J. Biol. Chem. 272:13849.[Abstract/Free Full Text]
  33. Helenius, A., E. S. Trombetta, D. N. Herbert, J. F. Simon. 1997. Calnexin and calreticulin and the folding of glycoproteins. Trends Cell Biol. 7:193.[Medline]
  34. Oliver, J. D., F. J. van der Wal, N. J. Bulleid, S. High. 1997. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 275:86.[Abstract/Free Full Text]
  35. Shimizu, Y., R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol. 142:3320.[Abstract]
  36. Myers, N. B., M. R. Harris, J. M. Connolly, L. Lybarger, Y. Y. L. Yu, T. H. Hansen. 2000. Kb, Kd, and Ld molecules share common tapasin dependencies as determined using a novel epitope tag. J. Immunol. 165:5656.[Abstract/Free Full Text]
  37. Ozato, K., T. H. Hansen, D. H. Sachs. 1980. Monoclonal antibodies to MHC antigens. II. Antibodies to the H-2Ld antigen, the product of a third polymorphic focus for the mouse major histocompatibility complex. J. Immunol. 125:2473.[Abstract]
  38. Shiroishi, T., G. A. Evans, E. Appella, K. Ozato. 1984. Role of a disulfide bridge in the immune function of a major histocompatibility class I antigen as studied by in vitro mutagenesis. Proc. Nat. Acad. Sci. USA 81:7544.[Abstract/Free Full Text]
  39. Lie, W.-R., N. B. Myers, J. M. Connolly, J. Gorka, D. R. Lee, T. H. Hansen. 1991. The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigen structure. J. Exp. Med. 173:449.[Abstract/Free Full Text]
  40. Smith, J. D., N. B. Myers, J. Gorka, T. H. Hansen. 1992. Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and at the cell surface. J. Exp. Med. 175:191.[Abstract/Free Full Text]
  41. Smith, J. D., N. B. Myers, J. Gorka, T. H. Hansen. 1993. Model for the in vivo assembly of nascent Ld class I molecules and for the expression of unfolded Ld molecules at the cell surface. J. Exp. Med. 178:2035.[Abstract/Free Full Text]
  42. Meyer, T. H., P. M. Van Endert, S. Uebel, B. Ehring, R. Tampe. 1994. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett. 351:443.[Medline]
  43. Brodsky, F. M., P. Parham, C. J. Barnstable, M. J. Crumpton, W. F. Bodmer. 1979. Monoclonal antibodies for analysis of the HLA system. Immunol. Rev. 47:362.
  44. Li, S., H-O. Sjögren, U. Hellmen, R. F. Pettersson, P. Wang. 1997. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 94:8708.[Abstract/Free Full Text]
  45. Ware, F. E., A. Vassilakos, P. A. Peterson, M. R. Jackson, M. A. Lehrman, D. B. Williams. 1995. The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J. Biol. Chem. 270:4697.[Abstract/Free Full Text]
  46. Zhang, Q., M. Tector, R. D. Salter. 1995. Calnexin recognizes carbohydrate and protein determinants of class I major histocompatibility complex molecules. J. Biol. Chem. 270:3944.[Abstract/Free Full Text]
  47. Zapun, A., S. M. Petrescu, P. M. Rudd, R. A. Dwek, D. Y. Thomas, J. J. M. Bergeron. 1997. Conformation-independent binding of monoglucosylated ribonuclease B to calnexin. Cell 88:29.[Medline]
  48. Tector, M., Q. Zhang, R. S. Salter. 1997. {beta}2m-microglobulin and calnexin can independently promote folding and disulfide bond formation in class I histocompatibility proteins. Mol. Immunol. 34:401.[Medline]
  49. Farmery, M. R., S. Allen, A. J. Allen, J. J. Bulleid. 2000. The role of ERp57 in disulfide bond formation during the assembly of major histocompatibility complex class I in a synchronized semipermeablized cell translation system. J. Biol. Chem. 275:14933.[Abstract/Free Full Text]
  50. Diedrich, G., N. Bangia, M. Pan, P. Cresswell. 2001. A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum. J. Immunol. 166:1703.[Abstract/Free Full Text]
  51. Copeman, J., N. Bangia, J. C. Cross, Peter Cresswell. 1998. Elucidation of the genetic basis of the antigen presentation defects in the mutant cell line .220 reveals polymorphism and alterative splicing of the tapasin gene. Eur. J. Immunol. 28:3783.[Medline]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Martayan, L. Sibilio, A. Setini, E. L. Monaco, E. Tremante, D. Fruci, M. Colonna, and P. Giacomini
N-Linked Glycosylation Selectively Regulates the Generic Folding of HLA-Cw1
J. Biol. Chem., June 13, 2008; 283(24): 16469 - 16476.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Sibilio, A. Martayan, A. Setini, R. Fraioli, D. Fruci, J. Shabanowitz, D. F. Hunt, and P. Giacomini
Impaired Assembly Results in the Accumulation of Multiple HLA-C Heavy Chain Folding Intermediates
J. Immunol., November 15, 2005; 175(10): 6651 - 6658.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Chen, P. Tabaczewski, S. M. Truscott, L. Van Kaer, and I. Stroynowski
Hepatocytes Express Abundant Surface Class I MHC and Efficiently Use Transporter Associated with Antigen Processing, Tapasin, and Low Molecular Weight Polypeptide Proteasome Subunit Components of Antigen Processing and Presentation Pathway
J. Immunol., July 15, 2005; 175(2): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. A. York, E. P. Grant, A. M. Dahl, and K. L. Rock
A Mutant Cell with a Novel Defect in MHC Class I Quality Control
J. Immunol., June 1, 2005; 174(11): 6839 - 6846.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Tourdot, M. Nejmeddine, S. J. Powis, and K. G. Gould
Different MHC Class I Heavy Chains Compete with Each Other for Folding Independently of {beta}2-Microglobulin and Peptide
J. Immunol., January 15, 2005; 174(2): 925 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Petersen, H. D. Hickman-Miller, M. M. McIlhaney, S. E. Vargas, A. W. Purcell, W. H. Hildebrand, and J. C. Solheim
A Charged Amino Acid Residue in the Transmembrane/Cytoplasmic Region of Tapasin Influences MHC Class I Assembly and Maturation
J. Immunol., January 15, 2005; 174(2): 962 - 969.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Wang, L. Lybarger, R. Connors, M. R. Harris, and T. H. Hansen
Model for the Interaction of Gammaherpesvirus 68 RING-CH Finger Protein mK3 with Major Histocompatibility Complex Class I and the Peptide-Loading Complex
J. Virol., August 15, 2004; 78(16): 8673 - 8686.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Z. Frenkel, M. Shenkman, M. Kondratyev, and G. Z. Lederkremer
Separate Roles and Different Routing of Calnexin and ERp57 in Endoplasmic Reticulum Quality Control Revealed by Interactions with Asialoglycoprotein Receptor Chains
Mol. Biol. Cell, May 1, 2004; 15(5): 2133 - 2142.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. R. Turnquist, J. L. Petersen, S. E. Vargas, M. M. McIlhaney, E. Bedows, W. E. Mayer, A. G. Grandea III, L. Van Kaer, and J. C. Solheim
The Ig-Like Domain of Tapasin Influences Intermolecular Interactions
J. Immunol., March 1, 2004; 172(5): 2976 - 2984.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Chefalo, A. G. Grandea III, L. Van Kaer, and C. V. Harding
Tapasin-/- and TAP1-/- Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH
J. Immunol., June 15, 2003; 170(12): 5825 - 5833.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Miley, S. M. Truscott, Y. Y. L. Yu, S. Gilfillan, D. H. Fremont, T. H. Hansen, and L. Lybarger
Biochemical Features of the MHC-Related Protein 1 Consistent with an Immunological Function
J. Immunol., June 15, 2003; 170(12): 6090 - 6098.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M.-E. Paquet and D. B. Williams
Mutant MHC class I molecules define interactions between components of the peptide-loading complex
Int. Immunol., April 1, 2002; 14(4): 347 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Y. L. Yu, M. R. Harris, L. Lybarger, L. A. Kimpler, N. B. Myers, H. W. Virgin IV, and T. H. Hansen
Physical Association of the K3 Protein of Gamma-2 Herpesvirus 68 with Major Histocompatibility Complex Class I Molecules with Impaired Peptide and {beta}2-Microglobulin Assembly
J. Virol., February 22, 2002; 76(6): 2796 - 2803.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Tan, H. Kropshofer, O. Mandelboim, N. Bulbuc, G. J. Hammerling, and F. Momburg
Recruitment of MHC Class I Molecules by Tapasin into the Transporter Associated with Antigen Processing-Associated Complex Is Essential for Optimal Peptide Loading
J. Immunol., February 15, 2002; 168(4): 1950 - 1960.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Lankat-Buttgereit and R. Tampe
The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases
Physiol Rev, January 1, 2002; 82(1): 187 - 204.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. R. Harris, L. Lybarger, N. B. Myers, C. Hilbert, J. C. Solheim, T. H. Hansen, and Y. Y. L. Yu
Interactions of HLA-B27 with the peptide loading complex as revealed by heavy chain mutations
Int. Immunol., October 1, 2001; 13(10): 1275 - 1282.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, M. R.
Right arrow Articles by Hansen, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, M. R.
Right arrow Articles by Hansen, T. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS